Logo image of ZIVO

ZIVO BIOSCIENCE INC (ZIVO) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ZIVO - US98978N3098 - Common Stock

1.1 USD
-0.05 (-4.35%)
Last: 11/24/2023, 8:12:49 PM
1.12 USD
+0.02 (+1.82%)
After Hours: 11/24/2023, 8:12:49 PM
Fundamental Rating

0

ZIVO gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 36 industry peers in the Personal Care Products industry. Both the profitability and financial health of ZIVO have multiple concerns. ZIVO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • ZIVO had negative earnings in the past year.
  • ZIVO had a negative operating cash flow in the past year.
ZIVO Yearly Net Income VS EBIT VS OCF VS FCFZIVO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -5M -10M

1.2 Ratios

  • With a Return On Assets value of -404.76%, ZIVO is not doing good in the industry: 94.87% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -404.76%
ROE N/A
ROIC N/A
ROA(3y)-1550.36%
ROA(5y)-2266.53%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZIVO Yearly ROA, ROE, ROICZIVO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 20K 40K 60K 80K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ZIVO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZIVO Yearly Profit, Operating, Gross MarginsZIVO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 -10K -20K -30K -40K

0

2. Health

2.1 Basic Checks

  • The number of shares outstanding for ZIVO remains at a similar level compared to 1 year ago.
  • The debt/assets ratio for ZIVO is higher compared to a year ago.
ZIVO Yearly Shares OutstandingZIVO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 500K 1M 1.5M
ZIVO Yearly Total Debt VS Total AssetsZIVO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M

2.2 Solvency

  • Based on the Altman-Z score of -94.02, we must say that ZIVO is in the distress zone and has some risk of bankruptcy.
  • ZIVO's Altman-Z score of -94.02 is on the low side compared to the rest of the industry. ZIVO is outperformed by 97.44% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -94.02
ROIC/WACCN/A
WACCN/A
ZIVO Yearly LT Debt VS Equity VS FCFZIVO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 10M -10M -20M

2.3 Liquidity

  • A Current Ratio of 0.62 indicates that ZIVO may have some problems paying its short term obligations.
  • With a Current ratio value of 0.62, ZIVO is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.62 indicates that ZIVO may have some problems paying its short term obligations.
  • ZIVO has a worse Quick ratio (0.62) than 71.79% of its industry peers.
Industry RankSector Rank
Current Ratio 0.62
Quick Ratio 0.62
ZIVO Yearly Current Assets VS Current LiabilitesZIVO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M

0

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.67% over the past year.
EPS 1Y (TTM)1.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.97%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y85.38%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZIVO Yearly Revenue VS EstimatesZIVO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2023 200K 400K 600K 800K
ZIVO Yearly EPS VS EstimatesZIVO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 -1 -2 -3 -4 -5

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ZIVO. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ZIVO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZIVO Price Earnings VS Forward Price EarningsZIVO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZIVO Per share dataZIVO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • ZIVO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ZIVO BIOSCIENCE INC / ZIVO FAQ

Can you provide the ChartMill fundamental rating for ZIVO BIOSCIENCE INC?

ChartMill assigns a fundamental rating of 0 / 10 to ZIVO.


What is the valuation status of ZIVO BIOSCIENCE INC (ZIVO) stock?

ChartMill assigns a valuation rating of 0 / 10 to ZIVO BIOSCIENCE INC (ZIVO). This can be considered as Overvalued.


How profitable is ZIVO BIOSCIENCE INC (ZIVO) stock?

ZIVO BIOSCIENCE INC (ZIVO) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for ZIVO stock?

The Earnings per Share (EPS) of ZIVO BIOSCIENCE INC (ZIVO) is expected to grow by 85.38% in the next year.